Replies to post #256447 on Biotech Values

[vinmantoo]

DAWN acquires MRSN for $25.00/sh cash +CVR—a 182% premium to yesterday’s closing price (excluding the CVR):

Good for MRSN shareholders. I hadn't thought about MRSN in quite a while.

[DewDiligence]

Servier acquires DAWN for $21.50.sh cash—a 68% premium to yesterday’s close:

https://www.globenewswire.com/news-release/2026/03/06/3251033/0/en/Servier-and-Day-One-Biopharmaceuticals-announce-acquisition-to-expand-Servier-s-rare-oncology-portfolio.html

The nominal deal value is $2.5B. Servier, which is private, is the second largest drug company based in France.